NW-1048

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameNW-1048
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitors
TargetsMonoamine oxidase B
Therapy Area/IndicationsEpilepsyParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNewron Pharmaceuticals Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNewron Pharmaceuticals Spa
Active IndicationsN/A
Inactive IndicationsEpilepsyParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A